mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.4 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.4 |
mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.4 |
mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.4 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.061 |
0.4 |
mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.4 |